Patents by Inventor Elisa Wurmbach

Elisa Wurmbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of intrinsic reporters of cell signaling for high content drug profiling and toxicity screening
    Patent number: 7723023
    Abstract: The present invention identifies essentially all of the members of a specific group of genes that are preferentially transcribed upon the initialization of a signal transduction pathway. The present invention also discloses methods for detecting and/or quantifying the transcription of these specific genes. The present invention further discloses methods of using this information to characterize the effect of potential drugs on a cell. Solid supports comprising nucleic acids that can hybridize with the transcripts from this specific group of genes are also described.
    Type: Grant
    Filed: August 14, 2002
    Date of Patent: May 25, 2010
    Assignee: Mount Sinai School of Medicine
    Inventors: Stuart Sealfon, Elisa Wurmbach, Tony Yuen
  • Use of intrinsic reporters of cell signaling for high content drug profiling and toxicity screening
    Publication number: 20030165916
    Abstract: The present invention identifies essentially all of the members of a specific group of genes that are preferentially transcribed upon the initialization of a signal transduction pathway. The present invention also discloses methods for detecting and/or quantifying the transcription of these specific genes. The present invention further discloses methods of using this information to characterize the effect of potential drugs on a cell. Solid supports comprising nucleic acids that can hybridize with the transcripts from this specific group of genes are also described.
    Type: Application
    Filed: August 14, 2002
    Publication date: September 4, 2003
    Inventors: Stuart Sealfon, Elisa Wurmbach, Tony Yuen